Clinical trial

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive

NCT01668914

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention IM-SLNB Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention 99mTc-SC Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Histologic Examination Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention LSG Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Methylthioninium Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

IM-SLNBPROCEDURE

99mTc-SCRADIATION

Histologic ExaminationDEVICE

LSGDEVICE

MethylthioniniumDRUG

Sponsors & collaborators

Shandong Cancer Hospital and Institutelead sponsor

Mapped research locations

JinanShandong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01668914 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.